Seeking Alpha

John Cordes » Comments » ACTC

  • Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]
    KOOL Thermogenics, little debt, cash flow, specialty service and equipement to stem cell industry, with unique products and long term expertise. It's not neccessary to guess which bio-tech/stem cell company will break out, they all use Thermogenic products.
    Mar 13 09:31 am |Rating: 0 0 |Link to Comment
More on ACTC by John Cordes
Comments by Ticker
AAPL, ABAT.OB, ABT, ACH, ACTC, ACTS, AKNS, ALXN, AMCN, APOG, APWR, ARIA, ASTI, ASTM, ATAI, ATSAF.PK, ATV, AVR, AXPW.OB, BA, BAC, BBY, BIDU, BK, BRK.A, BRK.B, BTIM, BYDDF.PK, C, CAT, CBAI, CBAK, CEA, CEDU, CEF, CEG, CELG, CEO, CHA, CHL, CHU, CISG, CIT, CL, CLNE, CMED, CMM, CNTF, COF, CPC,
John Cordes'
Comments Stats
102 comments
Rating: 82 (148 - 66 )